The Claim

Thyrotropin receptor-stimulating immunoglobulins from patients with Graves' disease induce significant hyaluronan synthesis in differentiated orbital fibroblasts from individuals with severe Graves' ophthalmopathy, while recombinant human TSH does not induce significant hyaluronan synthesis in the same cell type, despite both agents triggering cAMP signaling in most cultures.

Source: Thyrotropin Receptor-Stimulating Graves' Disease Immunoglobulins Induce Hyaluronan Synthesis by Differentiated Orbital Fibroblasts from Patients with Graves' Ophthalmopathy Not Only Via Cyclic Adenosine Monophosphate Signaling Pathways

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
33score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Antibodies from people with Graves' disease cause orbital fibroblasts to produce large amounts of hyaluronan, but thyroid-stimulating hormone does not, even though both activate the same signaling pathway.

See the scientific wording

Thyrotropin receptor-stimulating immunoglobulins from patients with Graves' disease induce significant hyaluronan synthesis in differentiated orbital fibroblasts from 17 patients with severe Graves' ophthalmopathy, whereas recombinant human TSH does not, despite both triggering cAMP signaling in most cultures, suggesting that hyaluronan production is not primarily mediated by cAMP in this context.

Why this might work

Antibodies from people with Graves' disease bind to a receptor on eye tissue cells, activating a cellular pathway that does not involve the common cAMP signal. This alternative pathway turns on genes that make a swelling substance called hyaluronan, which builds up and causes tissue expansion in the eye socket.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Thyrotropin Receptor-Stimulating Graves' Disease Immunoglobulins Induce Hyaluronan Synthesis by Differentiated Orbital Fibroblasts from Patients with Graves' Ophthalmopathy Not Only Via Cyclic Adenosine Monophosphate Signaling Pathways

    In people with Graves' disease, certain antibodies make eye tissue cells produce a gooey substance called hyaluronan, which causes swelling — but the thyroid hormone doesn't do this, even though both activate the same cellular signal. So the swelling isn't caused by that signal alone.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.